AHK-Cu

Skin & hair Research only Cell culture only

Also called Copper tripeptide AHK, Ala-His-Lys copper

A three-amino-acid peptide carrying a copper ion, the close relative of GHK-Cu. Where GHK-Cu is associated mostly with skin, AHK-Cu is marketed for hair, on the basis that it supports the blood vessels feeding the follicle.

Evidence at a glance

Evidence
Preliminary — Very little published work
Status
Research compound only
Dosing
No human study has set a dose

The evidence is cell and tissue culture, not people. AHK-Cu has nothing like the controlled topical trial record that GHK-Cu has, and the two are often marketed as interchangeable when only one has been tested on human skin.

What studies report

How it works

Delivers copper into cells, as GHK-Cu does, and is associated with raised VEGF signalling around the hair follicle, which would increase the blood supply a growing follicle depends on.

Binds a receptor on the cell surface and signals inward

Where it acts

Acts in the skin, throughout the body

The library groups this compound under Skin & hair. The diagram shows that target, not every tissue it reaches.

Illustrated

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.

Why people take it

Hair growthHair thicknessScalp healthSkin collagen

Reasons people seek it out — not a list of proven effects.

In practice Unapproved use

Reported real-world use, not evidence and not a recommendation.

Status: Used as a cosmetic ingredient. Not an approved medicine.

Route
Topical on skin or scalp
Sequence
Ala-His-Lys · Cu²⁺
Available as
50 mg, 100 mg
View on PubChem →

Search PubMed for AHK-Cu → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.